Danaher Co. (NYSE:DHR) declared a quarterly dividend on Tuesday, May 8th, RTT News reports. Stockholders of record on Friday, June 29th will be paid a dividend of 0.16 per share by the conglomerate on Friday, July 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.65%. The ex-dividend date of this dividend is Thursday, June 28th.
Danaher has increased its dividend by an average of 18.8% per year over the last three years. Danaher has a payout ratio of 14.0% meaning its dividend is sufficiently covered by earnings. Analysts expect Danaher to earn $4.82 per share next year, which means the company should continue to be able to cover its $0.56 annual dividend with an expected future payout ratio of 11.6%.
Shares of Danaher opened at $99.12 on Wednesday, according to MarketBeat. The stock has a market cap of $69.06 billion, a PE ratio of 24.60, a P/E/G ratio of 1.85 and a beta of 1.03. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.59 and a quick ratio of 1.15. Danaher has a 52 week low of $78.97 and a 52 week high of $104.82.
Danaher (NYSE:DHR) last announced its quarterly earnings data on Thursday, April 19th. The conglomerate reported $0.99 EPS for the quarter, beating the Zacks’ consensus estimate of $0.94 by $0.05. The business had revenue of $4.70 billion during the quarter, compared to analyst estimates of $4.54 billion. Danaher had a net margin of 13.56% and a return on equity of 11.39%. The firm’s revenue for the quarter was up 11.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.85 earnings per share. equities analysts predict that Danaher will post 4.45 EPS for the current year.
In other news, Director Linda P. Hefner sold 18,001 shares of the firm’s stock in a transaction that occurred on Thursday, April 26th. The shares were sold at an average price of $101.51, for a total transaction of $1,827,281.51. Following the completion of the sale, the director now owns 25,225 shares of the company’s stock, valued at $2,560,589.75. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Thomas Patrick Joyce, Jr. sold 120,354 shares of the firm’s stock in a transaction that occurred on Friday, April 20th. The stock was sold at an average price of $101.17, for a total transaction of $12,176,214.18. Following the sale, the insider now directly owns 151,959 shares of the company’s stock, valued at approximately $15,373,692.03. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 241,940 shares of company stock valued at $24,527,925. Company insiders own 11.90% of the company’s stock.
A number of research analysts have recently commented on the stock. Zacks Investment Research lowered shares of Danaher from a “hold” rating to a “sell” rating in a research report on Wednesday, June 20th. ValuEngine lowered shares of Danaher from a “buy” rating to a “hold” rating in a research report on Thursday, June 21st. Barclays reissued a “buy” rating and issued a $113.00 price target on shares of Danaher in a research report on Friday, April 20th. Morgan Stanley increased their price target on shares of Danaher from $112.00 to $113.00 and gave the stock an “overweight” rating in a research report on Friday, April 20th. Finally, Robert W. Baird reissued a “buy” rating and issued a $106.00 price target on shares of Danaher in a research report on Friday, April 20th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and thirteen have given a buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $105.69.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.